Medications for opioid use disorder see massive spikes in funding

400 percent during the 6-year period.

“Research suggests that despite the growing need for treatment among individuals with opioid use disorder, many are not receiving treatment and many do not even have access to treatment,” she said.

These states may see considerable reductions in Medicaid funding if the American Health Care Act passes, which would restrict its growth rate through spending caps. Although the legislation will still provide $2 billion in OUD treatment, the researchers questioned whether the amount will properly fund states and their residents in need of addiction care.

“Opioid use disorder is a chronic, relapsing condition, and buprenorphine and methadone treatment is highly effective,” Clemans said. “Patients and their families should be able to access to effective treatment options that include a continuum of care to support recovery — from low-intensity treatment with maintenance medications to more intensive services when needed, such as partial hospitalization up to inpatient/detoxification services with medication treatment.

“Getting these people into effective treatment has benefits for the individual and their family, as well as benefits and savings for the community,” she added.